SHANDONG PHARMACEUTICAL GLASS CO.LTD Shandong Pharmaceutical Glass Co.Ltd Share Price
Equities
600529
CNE000001BG9
Non-Paper Containers & Packaging
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.51 CNY | -0.70% |
|
-9.95% | +11.37% |
| Sales 2024 * | 5.65B 779M 64.96B | Sales 2025 * | 6.49B 896M 74.71B | Capitalization | 18.92B 2.61B 218B |
|---|---|---|---|---|---|
| Net income 2024 * | 995M 137M 11.45B | Net income 2025 * | 1.17B 161M 13.45B | EV / Sales 2024 * | 2.8 x |
| Net cash position 2024 * | 3.1B 427M 35.63B | Net cash position 2025 * | 3.69B 509M 42.41B | EV / Sales 2025 * | 2.35 x |
| P/E ratio 2024 * |
19
x | P/E ratio 2025 * |
16.2
x | Employees | - |
| Yield 2024 * |
1.7% | Yield 2025 * |
1.99% | Free-Float | 78.59% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.70% | ||
| 1 week | -9.95% | ||
| Current month | -1.28% | ||
| 1 month | -2.99% | ||
| 3 months | +14.54% | ||
| 6 months | +6.14% | ||
| Current year | +11.37% |
1 week
27.42
32.26
1 month
27.4232.33
Current year
21.6132.33
1 year
21.6132.33
3 years
18.6345.45
5 years
18.0176.85
10 years
5.2876.85
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Zhang
CEO | Chief Executive Officer | 54 | 11/13/11 |
Yi Zhao Song
DFI | Director of Finance/CFO | 50 | 11/13/11 |
Yong Gang Hu
CHM | Chairman | 69 | 20/10/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yong Gang Hu
CHM | Chairman | 69 | 20/10/20 |
Hai Bao Zhao
SEC | Corporate Secretary | 57 | 20/10/20 |
Xing Jun Wang
BRD | Director/Board Member | 52 | 11/13/11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 28.51 | -0.70% | 12,642,850 |
| 25/24/25 | 28.71 | +0.81% | 11,781,590 |
| 24/24/24 | 28.48 | +2.26% | 22,090,320 |
| 23/24/23 | 27.85 | -9.99% | 26,431,240 |
| 22/24/22 | 30.94 | -2.27% | 11,819,460 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
SHANDONG PHARMACEUTICAL GLASS CO., LTD is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical glass products. The Company's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The Company distributes its products in domestic and overseas markets.
Calendar
16/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
28.51
CNY
Average target price
34.95
CNY
Spread / Average Target
+22.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.37% | 2.61B | |
| +3.90% | 4.52B | |
| +4.69% | 3.38B | |
| -8.00% | 2.35B | |
| -12.06% | 1.18B | |
| -18.80% | 688M | |
| 0.00% | 598M | |
| +6.75% | 375M | |
| -27.19% | 299M | |
| -36.73% | 228M |
- Stock Market
- Equities
- 600529 Stock
